This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Consider it a testament to the ubiquity and flexibility of the endocannabinoid system: we can inhale medicinal cannabinoids via combustion or vaporization; ingest them via food or drink; and absorb them directly through the skin, the bodys largest organ. Clinical benefits? So what do the studies say? The findings are mixed.
While animal studies have revealed that cannabinoid receptors likely have a role in modulating auditory signaling, there is no compelling data either from animal or human studies for the use of cannabinoids to alleviate tinnitus.” There could be a role for cannabinoids in the management of tinnitus through their anticonvulsant effects.
Evidence-based Complementary and Alternative Medicine published an article titled “Post-Traumatic Stress Disorder: Evidence-Based Research for the Third Millennium” which describes how profound the symptoms of PTSD can be: “Traumatic events are profoundly stressful.
Additionally, the ACPA reported on a clinicaltrial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. The endocannabinoid system consists of cannabinoid receptors all over the body. These damaged nerve fibers send incorrect signals to other pain centers.
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.
Oxford Cannabinoid Technologies Holdings plc. At the end of the programme, Evotec will provide the Company with a submission-ready regulatory document which will be used for submissions to regulatory agencies, as well as drug-batch approved and ready for First Time in Human clinicaltrials. & Notice of 2021 Final Results.
Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.
Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinicaltrials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. It’s not a new idea. That seemed to make all the difference.
In this article, we will explore the potential of medical cannabis as a treatment option for individuals diagnosed with PTSD, examining its scientific basis, clinical evidence, controversies, and future implications. Research suggests that cannabinoids may modulate these processes, potentially offering relief from PTSD symptoms.
This article was originally published on Analytical Cannabis and appears here with permission. . Of these consumers, over half said the drug had a beneficial clinical effect on their condition. More than 8 percent of those surveyed also reported already using cannabinoids, with 54 percent noting a beneficial clinical effect.
CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. Cannabinoids are the naturally occurring compounds found in the Cannabis plant. There are over 480 different Cannabinoids in the Cannabis plant. It is non-psychoactive and has a multitude of health benefits.
In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients. More rigorous clinicaltrials are needed to establish clear guidelines for its use in MS management.
This is because it contains cannabinoids, which have anti-inflammatory properties. Cannabinoids reduce inflammation in the body by limiting the amount of leukotrienes and prostaglandins that are released into your bloodstream when you’re injured, stressed or sick. Cannabis is anti-inflammatory.
Cannabinoids are a class of chemical compounds found in the cannabis plant. There are over 100 cannabinoids, and they are responsible for the plant’s therapeutic effects. Cannabinoids interact with our body’s endocannabinoid system, which regulates many important functions, including mood, appetite, and pain.
Understanding Cannabinoids: The Basics of CBD and THC Cannabinoids, CBD, THC—chances are you’ve heard these terms buzzing around lately, and for good reason! Cannabinoids are typically extracted from cannabis plants through a variety of methods. Once extracted, these cannabinoids interact with your body’s endocannabinoid system.
ClinicalTrial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population. We’ll never know for certain whether this article was intentionally designed to scare potential MMJ patients away.
The study, led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics , found anxiety was among the top three reasons for a medicinal cannabis prescription. This is despite a limited number of high-quality clinicaltrials investigating the drug’s efficacy for this condition. Read their full article at .
Cannabinoid receptors are distributed throughout the body and brain, and I think that also accounts for some of the varied effects of cannabis and the possibility that it can treat many different conditions. Which cannabinoids do you standardize for? She also translates Project CBD articles for its Japanese language site.
Animal studies are not only valuable, they can also be superior to clinicaltrials in some cases because they can circumvent human biases and expectancy effects, or perceptual and cognitive reactions to participation in cannabis-based experiments. The Hemp Farming Act of 2018. percent on a dry weight basis.”.
sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. 13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinicaltrials seems to support CBD’s positive effects on nociceptive pain (i.e.,
Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Metrics details.
There is certainly some evidence that cannabis may be helpful with increasing focus, in the right dose with the right terpenes and cannabinoids. Strain names are an unreliable method of finding cannabis that works for you, but for simplicity’s sake, these are the strains mentioned in the article: Harlequin ACDC Cannatonic.
Oxford Cannabinoid Technologies Holdings plc. . Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. Accelerated timelines to clinicaltrials and expansion of drug development pipeline. Phase 1 clinicaltrials are scheduled for Q3 2022 with Phase 2 trials expected in Q2 2023.
In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system.
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).
There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.
In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.
The study is published in the Journal of Medical Imaging and Radiation Sciences and titled Cannabis and Radiation Therapy: A Scoping Review of Human ClinicalTrials. ” According to the study, a total of 48 records were identified, and 8 articles were included after vetting. or ROBINS-I frameworks.
In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals.
In this article I’ll explain how and why these interactions occur and describe the classes of medications that are processed by the same liver enzymes the body uses to process CBD. Drug interactions reported in the scientific literature most often occur at very high doses used in clinicaltrials of epilepsy and other conditions.
We’re interested in how cannabinoids affect the nervous system, the brain, and in particular, we’re very interested in Alzheimer’s disease,” said Dr. Tyrell Towle, director of chemistry and extraction at MedPharm. View original article. Denver Company Moves Forward with Research License .
A recently published review article assessing the current state of research noted there were numerous studies supporting significant pain-managing effects. [3] A review article published in the journal, European Journal of Neuroscience , noted “promising results” and clear effects on inflammation, the source of much discomfort. [4]
Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.
This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research. CBD vs THC for Neuropathic Pain Management CBD and THC are the two primary cannabinoids in medical marijuana, and both have been shown to provide pain relief.
CANNABIS CULTURE – The results are now in after the first-ever legal clinicaltrial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? It was also unique because it used whole-plant cannabis, rather than single-molecule extracts or synthetic pharmaceutical cannabinoids. . View original article.
Medicinal cannabis products such as capsules, creams, oils, lozenges, sprays and granulated flowers were approved for prescription 159,665 times between the start of Australia’s medicinal cannabis program in February 2016 and September 2021, research led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics shows.
The Tobacco Authority of Thailand, or TOAT, is one of two governmental entities that has looked to capitalize on the sale of cannabinoids as soon as it received approval from the Food and Drug Administration, or FDA. The TOAT and the GPO will spearhead government efforts to bring cannabis to the masses.
A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.
In this article, we explore the effectiveness of medical marijuana in easing chemotherapy side effects, offering insights into its benefits, challenges, and prospects. Medical marijuana refers to the use of cannabis and its cannabinoids to treat medical conditions, including the side effects of chemotherapy.
This system of receptors binds together with cannabinoids that our own bodies produce like anandamide, as well as exogenous forms of cannabinoids found in plants like THC and CBD. These cannabinoids are like keys that fit perfectly into our CB1 and CB2 receptors which are like locks. We’ll see you there!
In this article, we explore the scientific understanding of THC, exploring its chemical structure, mechanisms of action within the human body, potential health benefits, associated risks, and legal implications. THC interacts with cannabinoid receptors in the brain and nervous system, which are part of the endocannabinoid system (ECS).
In this comprehensive article, we’ll delve into the potential benefits and challenges of using MMJ as a treatment for epilepsy, as well as share the perspectives of both medical professionals and patients who have experienced the promising effects of MMJ on seizure control and overall well-being.
In this article, we will explore all the scientific evidence that evaluate the medical benefits of marijuana against its associated health risks in an attempt to answer this simple question: is marijuana/cannabis is good or bad for the human health. The approval is based on the research and clinicaltrials. Multiple sclerosis.
Article by Jorge P. This article will examine how courts have responded to claims for cannabis, as an element of future care costs, in personal injury cases. A modest award for the cost of Cesamet/Nabilone, the synthetic cannabinoid, was awarded in this case. June 6 2019. Cox & Palmer. Introduction. Fabretti v. ” 42.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content